Johnson & Johnson shares could rally about 20 percent to the mid-$130s as operating improvements spur earnings growth, Barron's said in a report. Healthcare stocks have taken a hit since U.S. President-elect Donald Trump vowed to bring down drug prices.
Go here to see the original:
Johnson & Johnson shares could rally about 20 percent: Barron’s
